ORMP Earnings

Quarterly EPS
$0.22
Q2 2024
$-0.48
Q3 2024
$-0.25
Q4 2024
$-0.19
Q1 2025
$0.32
Q2 2025
$1.16
Q3 2025
$0.23
Q4 2025
$0.94
Q1 2026
Latest RevenueN/A
Latest Net Income38.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026$0.94038.3M-100.0%+594.7%
Q4 2025$0.23010.0M+192.0%
Q3 2025$1.16048.4M+341.7%
Q2 2025$0.32013.3M+45.5%
Q1 2025-$0.192.0M-7642000-575.0%
Q4 2024-$0.250-10199000-175.8%
Q3 2024-$0.480-19642000-500.0%
Q2 2024$0.2209.2M-100.0%+833.3%
Q1 2024$0.0401.5M
Q4 2023$0.33013.3M
Q3 2023-$0.080-3284000
Q2 2023-$0.03674.0K-1313000
Oramed Pharmaceuticals (ORMP) — Earnings